Abbott has launched a “next-generation” delivery system to streamline the electrode implantation process for its Proclaim DRG neurostimulation system. This advancement aims to improve treatments for ...
Scientists have identified no less than 16 distinct types of nerve cells in the human dorsal root ganglion (DRG), ...
Abbott today announced the launch of its neuromodulation business’ next-generation delivery system, which will be used to streamline the implantation process for electrodes used as part of its ...